Abstract
A preliminary study to evaluate the efficacy of intrathecal hyaluronidase was carried out in nine children suffering from tuberculous meningitis with communicating hydrocephalus. This was followed by a randomized trial in which five cases were treated with intrathecal hyaluronidase, while six cases were treated by the insertion of a ventriculoperitoneal shunt. No untoward reaction of any significance was noted. The results were judged in terms of improvement in the sensorium and mentation, in specific neurological deficit (e.g., visual impairment and hemiparesis), and in overall functional performance. Although most of the patients receiving hyaluronidase showed some improvement in the sensorium, only one of the nine preliminary cases and one of the five cases in the randomized trial showed a total recovery of function. Two of the six shunted patients, however, showed complete recovery. Shunt insertion led to further improvement in two of the nine preliminary cases who had failed to respond to treatment with hyaluronidase. This preliminary study shows that intrathecal hyaluronidase does, in most cases, lead to an improvement in the sensorium but does not offer any particular advantage over shunt insertion in terms of regression of specific neurological deficit or overall functional improvement.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
American Trudeau Society (1954) A statement by the committee on therapy concerning treatment of tuberculous meningitis. Am Rev Tuberculosis 70:756–758 (as quoted in [21])
Bhagwati SN, Singhal BS (1970) Raised intracranial pressure as a mode of presentation in tuberculous meningitis. Neurology (India) 18:116
Bhagwati SN (1971) Ventriculoatrial shunt in tuberculous meningitis with hydrocephalus. J Neurosurg 35:309
Bhagwati SN, Singhal BS (1972) Raised intracranial pressure in tuberculous meningitis. Proceedings of the 3rd Asian and Oceanic Congress of Neurology, 1971. Neurology (India) [Suppl 1]20:80
Bhagwati SN (1974) Ventriculoatrial shunt in the treatment of tuberculous meningitis. In: Kapila PC, Dastur DK, Tandon PN (eds) WHO monograph on tuberculosis of the nervous system. Indian Academy of Medical Sciences, India, pp 77–82
Bhagwati SN (1982) Shunt and shunt problems in tuberculous meningitis with hydrocephalus. In: Choux M (ed) Monographs on ‘shunts and problems in shunts’ in neurological sciences, vol 8. Karger, Basel, pp 218–219
Bhagwati SN, Parulekar G (1984) Management of tuberculous meningitis with hydrocephalus — role of shunt surgery. Nat Inst Mental Health Neuro Sci J 2:55–58
Cathie IAB, Mcfarlane JCW (1950) Adjuvants to streptomycin in treating tuberculous meningitis in children. Lancet II:784–789
Dastur DK, Lalitha VS, Udani PM, Parekh U (1970) The brain and meninges in tuberculous meningitis. Gross pathology in 100 cases and pathogenesis. Neurology (India) 18:86–100
Dastur HM, Pandya SK, Rao MYC (1972) Aetiology of hydrocephalus in tuberculous meningitis. Neurology (India) [Suppl 1] 20:73–79
Deshpande DH, Bharucha EP, Mondkar VP (1969) Tuberculous meningitis in adults (a clinico-pathological study of 18 years). Neurology (India) 17:28–34
Freiman I, Geefhuysen J (1970) Evaluation of IT therapy with streptomycin and hydrocortisone in tuberculous meningitis. J Pediatr 87:895–901
Gourie-Devi M, Satish P (1980) Use of intrathecal hyaluronidase in spinal arachnoiditis complicating tuberculous meningitis. Indian J Med Res 71:97–109
Gourie-Devi M, Satish P (1980) Hyaluronidase as an adjuvant in the treatment of cranial arachnoiditis (hydrocephalus and optochiasmatic meningitis) complicating tuberculous meningitis. Acta Neurol Scand 62:368–381
Hockaday JM, Smith HMV (1966) Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle 47:75–91
Johnson AJ, Ayvazian JH, Tullett WS (1959) Crystalline pancreatic desoxyribonuclease as an adjunct to the treatment of pneumococcal meningitis. N Engl J Med 260:893–900
Lapin JH (1950) Successful medical treatment of obstructive hydrocephalus in tuberculous meningitis. NY State J Med 50:1615–1616
Lalitha VS, Marker FE, Dastur DK (1980) Tuberculosis of the central nervous system. Records of the JJ Group of Hospitals 1965–77. Neurology (India) 28:197–201
Luis Gegalion (1979) The use of hyaluronidase in the central nervous system. Surg Neurol 12:3–5
Owen G, Clerk SL (1956) Some effects of injections of hyaluronidase into the subarachnoid space of experimental animals. J Neurosurg 13:223–229
Parsons M (1979) Tuberculous meningitis — a handbook for clinicians. Oxford University Press, Oxford
Reddy PK, Abraham J, Chandy MJ, Mathai KV, Raman PT (1974) Shunt surgery in tuberculous meningitis. Silver Jubilee Souvenir (Department of Neurological Science), Vellore, pp 123–128
Singhal BS, Bhagwati SN, Syed AH, Land GW (1975) Raised intracranial pressure in tuberculous meningitis. Neurology (India) 23:32–39
Schwartzman J (1949) Hyaluronidase in pediatrics. J Pediatr 34:559–563
Udani PM, Parekh UC, Dastur DK (1972) Some neurological syndromes in the central nervous system in tuberculosis. Neurology (India) [Suppl] 20:63–69
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhagwati, S.N., George, K. Use of intrathecal hyaluronidase in the management of tuberculous meningitis with hydrocephalus. Child's Nerv Syst 2, 20–25 (1986). https://doi.org/10.1007/BF00274028
Issue Date:
DOI: https://doi.org/10.1007/BF00274028